Presenting author

Retsina Meyer

1 presentation

• T37. A phase Ib study evaluating safety, preliminary efficacy, and putative biomarkers of neuroplasticity for the novel neuroplastogen zalsupindole (DLX-001) in major depressive disorder

  2026 ASCP Annual Meeting